1. Introduction {#sec0005}
===============

Retroperitoneal masses adjacent to the adrenal gland may be misdiagnosed with adrenal tumors, and the natural course and the risk of malignancy vary according to the tumor morphology and the tumor size. Solitary fibrous tumors (SFT) usually originate from the pleura and rarely occur in the retroperitoneum, especially the adrenal area. Herein, we report a case of SFT which was difficult to differentiate from adrenal tumor accompanied by pheochromocytoma in the contralateral adrenal gland, along with a review of the literature. To the best of our knowledge, this is the first case of synchronous occurrence of SFT and pheochromocytoma. This work has been reported in line with the SCARE criteria \[[@bib0005]\].

2. Case report {#sec0010}
==============

The patient was a 62-year-old woman with a history of hypertension and gastric ulcer. Her regular medication was Ca blocker. In June 2008, ultrasonography revealed bilateral adrenal tumors during a regular checkup. She was referred to our department for treatment.

Physical examination revealed blood pressure of 142/81 mmHg, pulse rate of 72 beats/minute, and body temperature of 36.7 °C, and her abdomen was flat and soft with no tenderness. Blood test results were as follows: white blood cell count, 4860/mm^3^; red blood cell count, 465 × 10^4^/mm^3^; hemoglobin, 13.8 g/dL; hematocrit, 39.1%; platelets, 24.3 × 10^4^/mm^3^; creatinine, 0.6 mg/dL; adrenaline, 0.02 ng/mL; noradrenaline, 0.16 ng/mL; and dopamine, 0.01 ng/mL. A urine collection test (excretion) revealed the following: adrenaline, 10.6 μg/day; noradrenaline 105 μg/day, metanephrine, 0.22 mg/day; and normetanephrine, 4.48 mg/day.

Computed tomography (CT) revealed a tumor measuring 4.7 × 4.0 × 5.0 cm in the right adrenal gland, showing enhancement in the early phase and prolonged enhancement in the late phase. CT also revealed a tumor measuring 3.0 × 2.3 × 2.0 cm in the left adrenal gland, showing slow enhancement ([Fig. 1](#fig0005){ref-type="fig"}). Metaiodobenzylguanidine scintigraphy showed abnormal uptake only in the right adrenal gland. Based on these findings, a diagnosis of right adrenal pheochromocytoma and left adrenal benign tumor was considered to be likely. The patient underwent right adrenalectomy in July 2008, and pheochromocytoma was confirmed by pathology. The urinary metanephrine and normetanephrine levels decreased to within the normal range. She was followed without any treatment. Then, the size of the left adrenal tumor gradually increased. The catecholamine hormones were within normal range during the follow-up. Surgery was recommended when the tumor reached 8 cm in diameter in March 2015. But she refused it at this time. Afterward, she had back pain when the tumor increased to 10 cm in diameter in January 2016 ([Fig. 2](#fig0010){ref-type="fig"}). Thereafter, she underwent surgery.Fig. 1Computed tomography findings: (A) simple phase, (B) arterial phase, (C) excretory phase. Tumors are observed in the bilateral adrenal glands (see arrows).Fig. 1Fig. 2Computed tomography findings. A left adrenal tumor 10 cm in diameter is observed.Fig. 2

2.1. Operative findings {#sec0015}
-----------------------

The tumor and a part of left adrenal grand were resected through a transabdominal approach. After identifying the normal adrenal gland, combined resection of the tumor and part of the adrenal gland that adhered to the tumor was performed, and most of the normal adrenal gland was preserved. The tumor appeared to originate from periadrenal tissues. The operative time was 5 h and 15 min with blood loss of 2570 mL.

2.2. Histological findings {#sec0020}
--------------------------

The cut surface of the tumor was white to yellowish-white and multinodular with a well-defined margin. Hematoxylin and eosin staining showed proliferation of relatively homogeneous spindle-shaped cells with collagenous fibers. Immunostaining was positive for CD34 and STAT6 ([Fig. 3](#fig0015){ref-type="fig"}). In addition, adipose tissue was present between the normal adrenal gland and the tumor ([Fig. 4](#fig0020){ref-type="fig"}). Based on these findings, the tumor was diagnosed as SFT originating in the periadrenal region.Fig. 3(A) Hematoxylin and eosin staining, (B) CD34, (C) STAT6.Fig. 3Fig. 4Hematoxylin and eosin staining. A fat pad layer is observed between the adrenal gland and the tumor.Fig. 4

2.3. Postoperative course {#sec0025}
-------------------------

After surgery, adrenocorticosteroid was temporarily administered for prophylactic purposes for 8 days. The patient has had no recurrence for 2 years since the last surgery.

3. Discussion {#sec0030}
=============

SFT was described in 1931 by Klemperer et al. as a tumor derived from mesothelial mesenchymal cells of the pleura \[[@bib0010]\]. SFTs most frequently occur in the pleura. Extrapleural SFTs are rare, and tumor locations include the liver, retroperitoneum, meningis, and upper extremity \[[@bib0015]\]. Most SFTs are benign, whereas approximately 10% are malignant, but recurrence is observed even in benign SFTs \[[@bib0015]\]. Surgical treatment is the first choice \[[@bib0020]\]. Patients with residual cells in the surgical margin and those with a tumor ≥10 cm in diameter are likely to develop local recurrence and distant metastasis \[[@bib0025]\]. Histological findings are characterized by diverse patterns of proliferation of spindle-shaped tumor cells, which is called a patternless pattern \[[@bib0015]\]. Immunostaining is usually positive for CD34 and Bcl-2; however, disease specificity is low. A recent study of SFTs identified the NAB2-STAT6 fusion gene and reported that STAT6 is an SFT-specific marker \[[@bib0030]\].

There have been only nine case reports of SFTs that were diagnosed as adrenal tumor by clinical imaging in the English literature \[[@bib0035], [@bib0040], [@bib0045], [@bib0050], [@bib0055], [@bib0060], [@bib0065], [@bib0070]\] ([Table 1](#tbl0005){ref-type="table"}). The median diameter of the tumors was 9.5 cm (range 2.5--12 cm), and tumors at least 10 cm were observed in four patients on imaging studies. Among the seven patients in whom the data on invasion was available, invasion to the adrenal gland was observed in three patients. Total adrenalectomy was performed in all patients with a unilateral tumor. One patient with bilateral tumors underwent partial adrenalectomy \[[@bib0070]\].Table 1Nine reported cases with solitary fibrous tumor (SFT) diagnosed as adrenal tumor (including the present case).Table 1Case numberAuthorPublication yearAgeSexTumor sideMaximum size (cm)[a](#tblfn0005){ref-type="table-fn"}Adrenal presevationAdrenal involvementRelapseObservation period[b](#tblfn0010){ref-type="table-fn"}1Prevot et al. \[[@bib0030]\]199642FL6NoYesNo12 mo2Bongiovanni et al. \[[@bib0035]\]200023FL9NoYesUnknownUnknown3Shen et al. \[[@bib0040]\]200456ML6NoUnknownUnknownUnknown4Kakihara et al. \[[@bib0045]\]200739FL10NoNoNo20 mo5Ho et al. \[[@bib0050]\]201071MR11.7NoNoUnknownUnknown6Park et al. \[[@bib0055]\]201166FLUnknownNoUnknownUnknownUnknown7Treglia et al. \[[@bib0060]\]201433MR2.5NoYesUnknownUnknown8Toniato et al. \[[@bib0065]\]201454MB12YesNoNo18 mo9Kuribayashi et al.[c](#tblfn0015){ref-type="table-fn"}201972FL10YesNoNo24 mo[^1][^2][^3]

The management of bilateral adrenal tumors is sometimes challenging. In this case, right adrenalectomy had been performed for pheochromocytoma and left adrenal tumor was followed up. But the tumor size increased from 3 cm to 10 cm over seven years, then surgical resection was decided. Patients undergoing bilateral adrenalectomy cannot avoid adrenal insufficiency, and therefore, require administration of adrenocorticosteroid permanently. It was reported that 25% of such cases had acute adrenal insufficiency, and a death occurred due to insufficient management \[[@bib0075]\]. A study has reported that preservation of at least one-third of the adrenal gland is sufficient for preservation of adrenal function \[[@bib0080]\]. Therefore, the adrenal gland should be preserved as much as possible in patients with bilateral adrenal tumors and those with a history of unilateral adrenalectomy, unless high-grade malignant tumor is suspected. In the present case, no evidence of local invasion or distant metastasis had been found in imaging. These findings allowed us to consider the tumor as low grade malignancy or benign. To the best of our knowledge, there has been no report showing natural history of SFT adjacent to the adrenal gland over seven years.

4. Conclusion {#sec0035}
=============

We encountered a case of SFT adjacent to the adrenal gland and contralateral adrenal pheochromocytoma. After 7-year growth of SFT (3 cm--10 cm in diameter), tumor resection was performed with successful preservation of solitary adrenal gland. SFT in the periadrenal region is difficult to differentiate from adrenal tumor and can be invasive to the adrenal gland. However, partial adrenalectomy should be considered in patients with a history of unilateral adrenalectomy, as in the present case.
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[^1]: Radiographic evaluation except case3 (resected tumor size).

[^2]: After surgery.

[^3]: Present case B, Bilateral.
